Ben Stevens is an Editor at various publications including Outsourced Pharma and Gloucestershire Live. He specializes in themes such as cannabis and psychedelics, agriculture and farming, and sports broadcasting, with a focus on topics like cannabidiol (CBD), cannabis business, and cannabis regulation. Ben's work has been featured in notable outlets including Yahoo News UK, Bioprocess Online, and Edutopia.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Ben’s coverage mainly focuses on event coverage within the realm of sports, with particular emphasis on basketball and American football. Given this focus, he is likely to be most responsive to pitches that provide detailed previews or analyses of upcoming games or events in these sports.
For example, providing insights into key players' performances, injury updates, or emerging trends could be valuable for Ben's articles. Additionally, offering unique perspectives on coaching changes and their potential impact on teams might also garner his interest.
As there is no specific geographic focus mentioned for Ben's coverage area, pitches related to any NBA or NFL team matchup would be relevant regardless of location.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: James Duckenfield, Ben Stevens
Whilst expressing empathy with patients impacted by the recent German crackdown on cannabis flower, the head of the country's leading wholesaler is bullish about its prospects – with orders up 50% since its purchase by Canadian cannabis giant High Tide.
By: James Duckenfield, Ben Stevens
Earlier this month, we published new data from two separate Freedom of Information (FOI) requests providing the most complete and up-to-date picture yet of the UK's medical cannabis market.
By: Ben Stevens, James Duckenfield
As Chief Administrative Law Judge Derek Julius weighs his recommendation on moving cannabis to Schedule III, the DEA's own closing brief attacks nearly every witness who opposed it — bar one scientist inside its own ranks.
By: Ben Stevens
Australia's ongoing efforts to restrict its medical cannabis market, now the largest outside North America , are now taking aim at the special access scheme (SAS) framework on which the country's hundreds of thousands of annual prescriptions are based.
By: Ben Stevens
By Dr Stefan Broselid, Founder and Scientific Lead of ECS Restore , has filed a patent application for a non-cannabinoid formulation designed
By: Ben Stevens
No, not in the way it is in the majority of US states or Canada.
By: Ben Stevens, James Duckenfield
Curaleaf Holdings's takeover bid for its Canadian rival Aurora Cannabis has evolved into a public spat between the two cannabis giants over whose financial projections are honest, who would actually control the proposed new entity, and whether the current bid can even close on its own terms.
By: Ben Stevens, James Duckenfield
Despite the Council of State knocking back its initial attempt to derail the French authorities' latest crackdown on CBD, the head of the trade groups fighting the ban remain upbeat on its chances of success.
By: Ben Stevens
Britain is on course to become the first country in the world to formally authorise cannabidiol (CBD) as a novel food, as the Food Standards Agency (FSA) recommends three applications […]
By: Ben Stevens
Forty-eight years ago today, the world lost the inimitable Ronnie Peterson following injuries sustained during the 1978 Italian Grand Prix , possibly
